MT 631 Cytosine-β-D-arabinofuranoside, [5-3H(N)]-
Click here for Typical Certificate of Analysis
|
| (Cytarabine,
[5-3H(N)]-; Ara C, [5-3H(N)]-) |
|
MORpure™
HPLC purified,
Delivered ≥ 97% pure with dated HPLC radiochromatogram |
| Ethanol:water (1:1)
solution, 1 mCi/ml |
250 µCi
(9.25 MBq) $1160 |
| ≥
15 Ci(0.555 TBq)/mmol |
1 mCi (37
MBq)
$1970 |
| NextGen V-Vial - shipped on dry ice |
M.W. 243.22
 |
|
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis,
or data derived from its use to support regulatory filings. |
MC 109 Cytosine-β-D-arabinofuranoside, [2-14C]-
|
| Click
here for Typical Certificate of Analysis |
| (Cytarabine,
[2-14C]-; Ara-C, [2-14C]-) |
| MORpure™
HPLC
purified, Delivered ≥ 98% Pure with HPLC Radiochromatogram |
| Ethanol:water (1:1) solution;
100 µCi/ml |
|
≥ 45 mCi(1.67 GBq)/mmol |
50 µCi (1.85 MBq)
$3970 |
| NextGen V-Vial |
| M.W. 243.22 |
|
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis,
or data derived from its use to support regulatory filings. |
